To hear about similar clinical trials, please enter your email below
Trial Title:
Community Support Program for Lung Cancer Screening Volume II
NCT ID:
NCT06628167
Condition:
Lung Cancer
Conditions: Official terms:
Lung Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Non-Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Health Services Research
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Transportation
Description:
Participants with ordered low dose CT and participants with scheduled low dose CT are
offered free transportation to and from appointment. Participants with ordered low dose
CT are also offered assistance in connecting with scheduling staff.
Arm group label:
West Philadelphia
Intervention type:
Behavioral
Intervention name:
Scheduling
Description:
Participants with ordered low dose CT are offered assistance in connecting with
scheduling staff.
Arm group label:
West Philadelphia
Summary:
This is a West Philadelphia based community project to improve adherence to lung cancer
screening. The overall objective of this project is to demonstrate the impact of a
community support program (CSP) on improve adherence to LCS follow-up guidelines in an
urban environment. The study will target individuals in the Penn Medicine healthcare
system residing in Philadelphia with an upcoming or missed follow-up screening or orders
placed but who have not yet scheduled their screenings by offering free transportation
coordination to and from the appointment. The study team will also offer to connect those
with placed but unscheduled low dose CT orders to connect with Penn Medicine's scheduling
staff.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Upcoming or missed low dose CT for lung cancer screening
- Philadelphia resident
Exclusion Criteria:
- Lives outside Philadelphia city limits
Gender:
All
Minimum age:
18 Years
Maximum age:
89 Years
Healthy volunteers:
Accepts Healthy Volunteers
Start date:
October 1, 2024
Completion date:
April 8, 2025
Lead sponsor:
Agency:
University of Pennsylvania
Agency class:
Other
Source:
University of Pennsylvania
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06628167
